OPCI NY 2021
Multiple didactic sessions will be intertwined with live cases from the cath lab at St. Francis Hospital & Heart Center® and for the first-time international sites.
OPCI NY 2021 - Special Focus Session: Optimizing Pharmacotherapy View all
OPCI NY 2021 - Session I: Beneath the surface - Mastering Microvascular Dysfunction
OPCI NY 2021 - Session II: Foundations of Imaging and Physiology
OPCI NY 2021 - Session III: OPCI: Live from India
OPCI NY 2021 - Session IV: Step-by-step guide to intravascular imaging
OPCI NY 2021 - Session V: Mastering Advanced Coronary Physiology – Up for Debate
OPCI NY 2021 - Session VI: Intravascular Imaging and Physiology for CHIP PCI
OPCI NY 2021 - Session VII: Vascular Imaging and Physiology – What’s next?
Learning Objectives
• Perform image interpretation and understand proper technique for various intravascular imaging and physiology modalities.
• Discuss the appropriate imaging modality to be used depending upon the case scenario or interventional procedure.
• Appreciate the appropriate use of coronary physiology based on the clinical setting.
• Explain the implications of recent clinical trial data on the use of particular imaging and physiology modalities.
• Understand the utility of algorithmic approaches to intravascular imaging and coronary physiology modalities to comply with appropriate use criteria.
• Use imaging and physiology in a wide range of cases including complex PCI.
Course directors
Ziad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read More
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show Less
Allen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read More
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show Less
Martin Leon
Martin B. Leon, MD is Professor of Medicine at Columbia University Irving Medical Center (CUIMC)....
Read More
Martin B. Leon, MD is Professor of Medicine at Columbia University Irving Medical Center (CUIMC). Dr. Leon is also Director of Columbia Interventional Cardiovascular Care, Director of the Cardiac Catheterization Laboratories, and is on the Executive Board of the Columbia Structural Heart & Valve Center. He is a practicing interventional cardiologist at NewYork-Presbyterian Hospital in New York City. Dr. Leon is also the Founder and Chairman Emeritus of the Cardiovascular Research Foundation.
Dr. Leon has served as principal investigator for over 50 clinical trials that have helped shape the field of interventional cardiovascular medicine, including the following studies: STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis. Dr. Leon has co-authored over 1550 publications, has performed over 10,000 interventional procedures, and has had a major impact as a thought-leader and innovator in the expanding sub-specialty of interventional cardiovascular device and drug therapies.
He is the Director and Founder of Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier interventional cardiovascular meeting, which recently celebrated its 24th anniversary. Dr. Leon has also served as Director or Co-Director of more than 100 international educational programs in areas of interventional cardiology. Dr. Leon has received 10 international career achievement awards and was awarded an honorary degree from the University of Athens.
Show Less
Gary Mintz
Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF,...
Read More
Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF, New York, NY) and a Director of Transcatheter Cardiovascular Therapeutics (TCT). He is the author of more than 1000 peer reviewed articles, 60 book chapters, 4 books, and 850 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and (especially) intravascular imaging and physiology. In 2005, Dr. Mintz published his single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese. In 2014, Dr. Mintz received the Master of the Masters Career Achievement Award at the TCTAP-Cardiovascular Summit in Seoul, Korea; in 2015 Dr. Mintz received the Chien Foundation Outstanding Lectureship & Lifetime Achievement Award, also presented at TCTAP-Cardiovascular Summit in Seoul, Korea; in 2017 Dr. Mintz received the Outstanding Achievement Award at CBS 2017, Nanjing, China; in 2018 Dr. Mintz received the Career Achievement Award at NFIC in Krakow, Poland; and in 2020 Dr. Mintz received the Jiangsu Friendship Award from the People’s Government of Jiangsu Province, China, the highest award presented to a non-Chinese. He also serves as a Senior Scientist and Advisor at the Medstar Cardiovascular Research Network, Washington, DC. Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University (now part of Drexel University), in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty in 1978 and was ultimately promoted to Professor of Medicine in 1987 before joining CRF in 1991. His past appointments at CRF have included Chief Medical Officer and Editor-in-Chief (and one of the founders) of TCTMD.com.
Show Less
Jeffrey Moses
An internationally recognized interventional cardiologist, Dr. Moses has performed more than...
Read More
An internationally recognized interventional cardiologist, Dr. Moses has performed more than 20,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the vast majority of procedures. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Heart Center in Roslyn, NY.
Show Less
Evan Shlofmitz
Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at...
Read More
Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at St. Francis Hospital - The Heart Center in Roslyn, NY. He completed a fellowship in Interventional Cardiology at Georgetown University/MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC), a Cardiovascular Disease fellowship at Northwell Health and served as Chief Resident for Internal Medicine at New York Presbyterian Queens. He serves on SCAI's IHD Council and is a co-director of Optimizing PCI (OPCI). His research interests have centered on intravascular imaging, the treatment of calcified coronary artery disease, in-stent restenosis and the optimization of stent implantation, with more than 100 publications in peer-reviewed journals.
Show Less
Richard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read More
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show Less
Jonathan Hill
Consultant Interventional Cardiologist and Revascularisation Group Chair at Royal Brompton...
Read More
Consultant Interventional Cardiologist and Revascularisation Group Chair at Royal Brompton Hospital, London.
His clinical focus is on use of intravascular imaging in complex PCI , CTO and cardiogenic shock. His clinical research interests focus on optical coherence tomography, calcific coronary disease and percutaneous ventricular support. Dr Hill was global co-chief investigator for the DISRUPT CAD III study and has served as UK principal investigator for multiple interventional trials. He has served as a CTO and complex PCI proctor on a global basis and works closely with OPTIMA to focus on the development of OPTIMAL PCI. He is the founding co-director of the Complete Revascularisation (CoRe) meetings held every year in London.
Show Less
Ziad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read MoreZiad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show LessAllen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read MoreAllen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show LessMartin Leon
Martin B. Leon, MD is Professor of Medicine at Columbia University Irving Medical Center (CUIMC)....
Read MoreMartin B. Leon, MD is Professor of Medicine at Columbia University Irving Medical Center (CUIMC). Dr. Leon is also Director of Columbia Interventional Cardiovascular Care, Director of the Cardiac Catheterization Laboratories, and is on the Executive Board of the Columbia Structural Heart & Valve Center. He is a practicing interventional cardiologist at NewYork-Presbyterian Hospital in New York City. Dr. Leon is also the Founder and Chairman Emeritus of the Cardiovascular Research Foundation. Dr. Leon has served as principal investigator for over 50 clinical trials that have helped shape the field of interventional cardiovascular medicine, including the following studies: STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis. Dr. Leon has co-authored over 1550 publications, has performed over 10,000 interventional procedures, and has had a major impact as a thought-leader and innovator in the expanding sub-specialty of interventional cardiovascular device and drug therapies. He is the Director and Founder of Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier interventional cardiovascular meeting, which recently celebrated its 24th anniversary. Dr. Leon has also served as Director or Co-Director of more than 100 international educational programs in areas of interventional cardiology. Dr. Leon has received 10 international career achievement awards and was awarded an honorary degree from the University of Athens.
Show LessGary Mintz
Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF,...
Read MoreGary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF, New York, NY) and a Director of Transcatheter Cardiovascular Therapeutics (TCT). He is the author of more than 1000 peer reviewed articles, 60 book chapters, 4 books, and 850 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and (especially) intravascular imaging and physiology. In 2005, Dr. Mintz published his single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese. In 2014, Dr. Mintz received the Master of the Masters Career Achievement Award at the TCTAP-Cardiovascular Summit in Seoul, Korea; in 2015 Dr. Mintz received the Chien Foundation Outstanding Lectureship & Lifetime Achievement Award, also presented at TCTAP-Cardiovascular Summit in Seoul, Korea; in 2017 Dr. Mintz received the Outstanding Achievement Award at CBS 2017, Nanjing, China; in 2018 Dr. Mintz received the Career Achievement Award at NFIC in Krakow, Poland; and in 2020 Dr. Mintz received the Jiangsu Friendship Award from the People’s Government of Jiangsu Province, China, the highest award presented to a non-Chinese. He also serves as a Senior Scientist and Advisor at the Medstar Cardiovascular Research Network, Washington, DC. Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University (now part of Drexel University), in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty in 1978 and was ultimately promoted to Professor of Medicine in 1987 before joining CRF in 1991. His past appointments at CRF have included Chief Medical Officer and Editor-in-Chief (and one of the founders) of TCTMD.com.
Show LessJeffrey Moses
An internationally recognized interventional cardiologist, Dr. Moses has performed more than...
Read MoreAn internationally recognized interventional cardiologist, Dr. Moses has performed more than 20,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the vast majority of procedures. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Heart Center in Roslyn, NY.
Show LessEvan Shlofmitz
Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at...
Read MoreDr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at St. Francis Hospital - The Heart Center in Roslyn, NY. He completed a fellowship in Interventional Cardiology at Georgetown University/MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC), a Cardiovascular Disease fellowship at Northwell Health and served as Chief Resident for Internal Medicine at New York Presbyterian Queens. He serves on SCAI's IHD Council and is a co-director of Optimizing PCI (OPCI). His research interests have centered on intravascular imaging, the treatment of calcified coronary artery disease, in-stent restenosis and the optimization of stent implantation, with more than 100 publications in peer-reviewed journals.
Show LessRichard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read MoreDr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show LessJonathan Hill
Consultant Interventional Cardiologist and Revascularisation Group Chair at Royal Brompton...
Read MoreConsultant Interventional Cardiologist and Revascularisation Group Chair at Royal Brompton Hospital, London. His clinical focus is on use of intravascular imaging in complex PCI , CTO and cardiogenic shock. His clinical research interests focus on optical coherence tomography, calcific coronary disease and percutaneous ventricular support. Dr Hill was global co-chief investigator for the DISRUPT CAD III study and has served as UK principal investigator for multiple interventional trials. He has served as a CTO and complex PCI proctor on a global basis and works closely with OPTIMA to focus on the development of OPTIMAL PCI. He is the founding co-director of the Complete Revascularisation (CoRe) meetings held every year in London.
Show LessAgendas
OPCI NY 2021
World-leading experts will review relevant trial data, and discuss advancements in device concepts.
Read More
World-leading experts will review relevant trial data, and discuss advancements in device concepts.
Show Less
11 June
12 June
Robert Busch
Dr. Robert Busch, MD, practices Endocrinology, Diabetes, & Metabolism in Albany, NY at Endocrine...
Read More
Dr. Robert Busch, MD, practices Endocrinology, Diabetes, & Metabolism in Albany, NY at Endocrine Group. Dr. Robert Busch received his B.A. from Brandeis University,and his Medical Degree from the University of Pennsylvania. He served his Internship, Residency,and was Chief Medical Resident at North Shore University Hospital,prior to his endocrinology fellowship at Albany Medical College.
Show Less
Add to calendar
-
America/New_York
SGLT2 Inhibitors: A drug for Heart Failure, Diabetes or Renal disease? One Drug that does it all
Rita Jermyn
Dr Jermyn is the director of the center for advanced cardiac therapeutics at st francis hospital....
Read More
Dr Jermyn is the director of the center for advanced cardiac therapeutics at st francis hospital. She also holds an appointment as an assistant professor at the Albert Einstein College of Medicine where she completed her advanced heart failure and transplant fellowship.
Her research interests include ambulatory pulmonary artery pressure monitoring, cardiometabolic syndrome, and mechanical circulatory support. She is board certified in cardiology and heart failure.
Show Less
Add to calendar
-
America/New_York
Balancing ischemic and bleeding risk: Contemporary use of anti-platelet and anti-thrombotic therapy following PCI
Darshan Doshi
Dr. Darshan Doshi is an interventional cardiologist at the Massachusetts General Hospital who...
Read More
Dr. Darshan Doshi is an interventional cardiologist at the Massachusetts General Hospital who specializes in complex coronary interventions. He also helps directs the chronic total occlusions program, and leads imaging and physiology efforts in the cath lab.
Dr. Doshi received his BA from Columbia University’s Columbia College and his MD from Columbia University’s College of Physicians and Surgeons. He completed his internal medicine residency, and his cardiovascular medicine and interventional cardiology fellowships at the Columbia University Medical Center. Dr. Doshi also underwent additional dedicated training at Columbia in complex and high-risk interventional procedures. He was then recruited to join the faculty in the Division of Cardiology at the Massachusetts General Hospital.
Dr. Doshi also holds a MS in patient-oriented research from Columbia University’s Mailman School of Public Health with a research interest focused on clinical trials evaluating novel cardiovascular devices and therapeutics in interventional cardiology. He has authored several original manuscripts in translational and clinical cardiovascular medicine, and has published in the New England Journal of Medicine, Lancet, Journal of the American College of Cardiology, and Circulation, among many others.
Show Less
Add to calendar
Richard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read More
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show Less
Add to calendar
Jennifer Tremmel
An interventional cardiology at Stanford University Medical Center, Stanford, CA, USA. Features...
Read More
An interventional cardiology at Stanford University Medical Center, Stanford, CA, USA. Features in 2 videos on Wondr Medical. Jennifer Tremmel generally speaks on Coronary Interventions, Structural Cardiac Interventions, Microvascular Disease (MVD), and Stable Coronary Artery Disease (CAD).
Show Less
Add to calendar
Olga Toleva
Dr. Olga Toleva graduated Medicine in Sofia, Bulgaria, and completed Family Medicine residency at...
Read More
Dr. Olga Toleva graduated Medicine in Sofia, Bulgaria, and completed Family Medicine residency at the University of British Columbia, Vancouver, Canada. She subsequently practiced as a Family physician and after a year in practice entered the Internal Medicine residency program at UBC, Vancouver. Dr. Toleva completed her training in Adult Cardiology and Interventional cardiology at the University of Alberta, Edmonton, Canada. During her cardiology fellowship she also completed Masters in Public Health at The Harvard School of Public Health.
Dr. Toleva worked as an Assistant Professor in the University of Manitoba and an Interventional Cardiologist at St. Boniface Hospital from 2014 until March 2021. She was involved in Transcatheter Aortic Valve Replacement (TAVR) and coronary physiology. She focused on outcomes research, frailty, and quality of life assessments in the older adults who are the predominant population requiring TAVR.
Dr. Olga Toleva just moved to the US and is a new Interventional Cardiologist at Emory Healthcare, primarily located at Emory St. Joseph's Hospital. She is involved in Transcatheter Aortic Valve Replacement (TAVR) and coronary physiology microvascular dysfunction invasive testing in the cardiac catheterization laboratory. Dr. Toleva has a strong interest in Women's Heart Health with clinical work and research related to the diagnosis and therapy of Spontaneous Coronary Artery Dissection (SCAD), Myocardial infarction without obstructive coronary artery disease (MINOCA), and Micro Vascular Dysfunction (MVD) - chest pain syndromes without obstructive coronary disease. She will be part of the Emory Women's Heart Health Clinic focusing on the care of patients and performing research in the area. These conditions are predominantly seen in women and continue to be poorly understood and under-treated. Dr. Toleva has a high volume PCI and TAVR practice and is very active in the world of coronary and structural heart research and innovation.
Show Less
Add to calendar
Allen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read More
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show Less
Martin Leon
Martin B. Leon, MD is Professor of Medicine at Columbia University Irving Medical Center (CUIMC)....
Read More
Martin B. Leon, MD is Professor of Medicine at Columbia University Irving Medical Center (CUIMC). Dr. Leon is also Director of Columbia Interventional Cardiovascular Care, Director of the Cardiac Catheterization Laboratories, and is on the Executive Board of the Columbia Structural Heart & Valve Center. He is a practicing interventional cardiologist at NewYork-Presbyterian Hospital in New York City. Dr. Leon is also the Founder and Chairman Emeritus of the Cardiovascular Research Foundation.
Dr. Leon has served as principal investigator for over 50 clinical trials that have helped shape the field of interventional cardiovascular medicine, including the following studies: STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis. Dr. Leon has co-authored over 1550 publications, has performed over 10,000 interventional procedures, and has had a major impact as a thought-leader and innovator in the expanding sub-specialty of interventional cardiovascular device and drug therapies.
He is the Director and Founder of Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier interventional cardiovascular meeting, which recently celebrated its 24th anniversary. Dr. Leon has also served as Director or Co-Director of more than 100 international educational programs in areas of interventional cardiology. Dr. Leon has received 10 international career achievement awards and was awarded an honorary degree from the University of Athens.
Show Less
Ziad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read More
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show Less
Add to calendar
-
Which drugs when in CMD - Bruce Samuels
-
Call it what you want, it’s all just GDMT - Duane Pinto
-
Q&A with Panel Discussion
Bruce Samuels
Dr. Bruce Samuels is an interventional cardiologist on staff at Cedars-Sinai Medical Center...
Read More
Dr. Bruce Samuels is an interventional cardiologist on staff at Cedars-Sinai Medical Center (CSMC) in Los Angeles, California. Dr. Samuels completed his medical studies at Albert Einstein College of Medicine in New York before returning to Southern California to complete his residency and chief residency in Internal Medicine at Harbor-UCLA Medical Center. At CSMC, he trained in both general and interventional cardiology before joining the medical staff there. In addition to his clinical practice in coronary intervention, Dr. Samuels has actively participated in numerous interventional trials including IVUS guided therapy, coronary physiology and microvascular disease. He is also working closely with the Barbra Streisand Women’s Heart Center based at CSMC, working as an interventionalist in the active coronary reactivity research there. As co-chair of a 30-day readmissions task force, he has helped to shape policy for CSMC in its efforts to improve quality delivery of care. He has frequently been invited as faculty to many scientific meetings and is a sought after speaker for numerous peer educational platforms. Dr. Samuels is a fellow of the American College of Cardiology and is Board Certified in Internal Medicine, Cardiovascular Diseases, and Interventional Cardiology. He is married with three sons; his outside interests include contemporary art and long distance running.
Show Less
Duane Pinto
Dr. Pinto received his B.A., cum Laude, from Dartmouth College in Hanover, NH and M.D. degree...
Read More
Dr. Pinto received his B.A., cum Laude, from Dartmouth College in Hanover, NH and M.D. degree from the Georgetown University, cum Laude and Alpha Omega Alpha. He was an Intern, Resident, Chief Resident, General Cardiology Fellow and Interventional Cardiology Fellow at Harvard Medical School and Beth Israel Hospital, Boston, MA. Dr. Pinto is an Associate Professor of Medicine at Harvard Medical School and serves as the Director of the Cardiac Intensive Care Unit, Associate Chief of the Interventional Section and Director of the General Cardiology Fellowship Program at Beth Israel Deaconess Medical Center. He has been awarded cardiology fellow teaching and mentorship awards from Harvard Medical School. His clinical expertise is in general and interventional cardiology. In addition to a busy outpatient practice, he performs coronary and peripheral angioplasty and stenting procedures. These include stenting and other procedures in the heart, leg, abdominal and neck arteries. Dr. Pinto has research interests in a wide variety of topics including acute myocardial infarction studies, unstable angina studies, interventional trials, peripheral interventional trials specializing in clinical outcome, comparative effectiveness and cost-effectiveness studies. Dr. Pinto is the editor of the Controversies in Cardiology section for Circulation. He is a manuscript reviewer for the New England Journal, Circulation and the Journal of the American College of Cardiology. He has published over 75 articles in journals such as The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology and JAMA. His work highlights the management and outcomes of patients with cardiac and vascular disorders.
Show Less
Add to calendar
Hector Garcia-Garcia
Hector M. Garcia-Garcia, MD, PhD, is now serving as an attending cardiologist for MedStar Heart &...
Read More
Hector M. Garcia-Garcia, MD, PhD, is now serving as an attending cardiologist for MedStar Heart & Vascular Institute and director of the Coronary Invasive Imaging Core Lab. Prior to joining the MHVI medical staff, Dr. Garcia-Garcia served as Director of the Core Lab of Invasive Imaging at Cardialysis—a leading cardiology clinical research organization—and as researcher at the Erasmus Medical Center in Rotterdam, The Netherlands and Inselspital in Bern, Switzerland. He received both a Master’s and Doctorate degree from the Erasmus University of Rotterdam. An accomplished researcher, Dr. Garcia-Garcia has widely published in many international medical journals (more than 530 publications - H-index of 61), authored book chapters in most renowned cardiovascular textbooks and has presented at cardiology conferences world-wide. He is an expert in innovative cardiovascular technology. He has mentored seven PhD students and published their thesis.
Show Less
Add to calendar
Khady Fall
A physiology manager at Columbia University Medical Center, NY, US. Features in 1 video on Wondr...
Read More
A physiology manager at Columbia University Medical Center, NY, US. Features in 1 video on Wondr Medical. Khady Fall generally speaks on Intravascular Ultrasound (IVUS) and Coronary Optical Coherence Tomography (OCT).
Show Less
Add to calendar
Habib Samady
Dr Habib Samady is an interventional cardiologist and serves as President of the Georgia Heart...
Read More
Dr Habib Samady is an interventional cardiologist and serves as President of the Georgia Heart Institute, the heart and vascular program of Northeast Georgia Health System. He is also Director of the Georgia Center for Cardiovascular Biomechanics and Modeling and Adjunct Professor of Medicine at Emory University. Dr Samady is recognized as one of the foremost international experts in coronary physiology. He earned his medical degree from the University of Sheffield in England, and completed his residency training in both London and in Sheffield. He subsequently completed an internal medicine residency and chief residency at the University of Connecticut, before his fellowship in general cardiology, nuclear cardiology, and interventional cardiology at Yale University in Connecticut.
Show Less
Add to calendar
Akiko Maehara
Dr.Akiko Maehara is a Professor at Columbia University Medical Center and work as a Director of...
Read More
Dr.Akiko Maehara is a Professor at Columbia University Medical Center and work as a Director of Intravascualr Imaging and MRI Core Laboratories at Cardiovascular Research Foundation In New York. She is an expert of intravascular imging (Intraascular ultrasound, Optical coherence tomography, Infrared spectroscopy) to detect vulnerable plauqe and optimize PCI.
Show Less
Add to calendar
-
It’s all about the flow – Why physiology guided PCI should be the standard - Ajay Kirtane
-
It’s all about the plaque–Why imaging rules it all - Gregg Stone
-
Q&A with Panel Discussion
-
Stump the Panel–Unusual Left Main Cases - Rapid Fire - Gary Mintz
Gary Mintz
Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF,...
Read More
Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF, New York, NY) and a Director of Transcatheter Cardiovascular Therapeutics (TCT). He is the author of more than 1000 peer reviewed articles, 60 book chapters, 4 books, and 850 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and (especially) intravascular imaging and physiology. In 2005, Dr. Mintz published his single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese. In 2014, Dr. Mintz received the Master of the Masters Career Achievement Award at the TCTAP-Cardiovascular Summit in Seoul, Korea; in 2015 Dr. Mintz received the Chien Foundation Outstanding Lectureship & Lifetime Achievement Award, also presented at TCTAP-Cardiovascular Summit in Seoul, Korea; in 2017 Dr. Mintz received the Outstanding Achievement Award at CBS 2017, Nanjing, China; in 2018 Dr. Mintz received the Career Achievement Award at NFIC in Krakow, Poland; and in 2020 Dr. Mintz received the Jiangsu Friendship Award from the People’s Government of Jiangsu Province, China, the highest award presented to a non-Chinese. He also serves as a Senior Scientist and Advisor at the Medstar Cardiovascular Research Network, Washington, DC. Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University (now part of Drexel University), in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty in 1978 and was ultimately promoted to Professor of Medicine in 1987 before joining CRF in 1991. His past appointments at CRF have included Chief Medical Officer and Editor-in-Chief (and one of the founders) of TCTMD.com.
Show Less
George Dangas
Works at The Mount Sinai Hospital, New York, NY, USA. Features in 3 videos on Wondr Medical....
Read More
Works at The Mount Sinai Hospital, New York, NY, USA. Features in 3 videos on Wondr Medical. George Dangas generally speaks on Cardiovascular Pharmacotherapy, Acute Coronary Syndromes (ACS), Primary Percutaneous Coronary Intervention (PPCI), Transcatheter Aortic Valve Implantation (TAVR / TAVI), and Coronary Physiology.
Show Less
Gregg Stone
Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic...
Read More
Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 120 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. With a 2018 H-factor of 152, Dr. Stone was recently listed in Nature Medicine as one of the most prolific authors in science. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes, myocardial infarction and cardiogenic shock; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter valve repair and replacement; interventional hypertension and heart failure therapies; left atrial appendage closure; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; adjunctive interventional devices including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; contrast nephropathy; clinical trial design; and regulatory issues. Dr. Stone is the director of TCT, the world's largest symposium devoted to interventional cardiology and vascular medicine. Dr. Stone founded the annual National Interventional Cardiology Fellow's Course and Transcatheter Valve Therapies TVT), the Chronic Total Occlusion (CTO) Summit, and co-directs multiple other meetings in the US, China, Russia, Europe, S. Korea and elsewhere.
Show Less
Add to calendar
Rony Mathew
A senior consultant & interventional cardiologist at Lisie Heart Institute, Kochi, India....
Read More
A senior consultant & interventional cardiologist at Lisie Heart Institute, Kochi, India. Features in 1 video on Wondr Medical. Rony Mathew generally speaks on Coronary Optical Coherence Tomography (OCT) and Bifurcation.
Show Less
Add to calendar
S Ajit Mullasari
A director of cardiology at The Institute of Cardio-Vascular Diseases, Madras Medical Mission,...
Read More
A director of cardiology at The Institute of Cardio-Vascular Diseases, Madras Medical Mission, Chennai, India. Features in 2 videos on Wondr Medical. S Ajit Mullasari generally speaks on Fractional Flow Reserve (FFR), Instantaneous wave-Free Ratio (iFR), Coronary Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS), and Rotational Atherectomy (PVD).
Show Less
Add to calendar
Balbir Singh
A chairman of interventional cardiology at Medanta Medicity Hospital, Gurgaon, India. Features in...
Read More
A chairman of interventional cardiology at Medanta Medicity Hospital, Gurgaon, India. Features in 1 video on Wondr Medical. Balbir Singh generally speaks on Coronary Optical Coherence Tomography (OCT) and Left Main Stem (LMS).
Show Less
Add to calendar
Jasvindar Singh
Dr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization...
Read More
Dr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization Laboratory at Barnes-Jewish Hospital and Director of Interventional Cardiology. He specializes in coronary and peripheral vascular interventional procedures and spends most of his time in the cardiac catheterization laboratory. His expertise is in complex coronary intervention and also the endovascular treatment of renovascular hypertension, and peripheral arterial occlusive diseases. In addition, he has been involved in research ranging from new coronary devices to intravascular ultrasound and pressure/flow assessment of coronary vessels. He is the Principal Investigator in several high profile multicenter trials evaluating the above. He is actively involved in resident/fellow education and rotate in the coronary care unit twice a year. He has two interventional fellows per year who work closely with him during their training, he also serves as their attending in ½ day in patient clinic. He has second and third year cardiology fellows involved in clinical research protocols in the cath lab and their work has produced three instrumental abstracts/papers which in the first 12 months were presented at major cardiovascular society meetings. Dr. Singh is also the Chairman of ARCH, one of the largest Midwest Interventional Symposium.
Show Less
Add to calendar
Sunil Rao
Dr. Rao is Professor of Medicine at Duke University Medical Center, and the Section Chief of...
Read More
Dr. Rao is Professor of Medicine at Duke University Medical Center, and the Section Chief of Cardiology at the Durham VA Medical Center.
At the national level, Dr. Rao serves as the Editor-in-Chief for Circulation Cardiovascular Interventions, the interventional journal of the American Heart Association’s flagship Circulation family of journals. He is the President-Elect for The Society for Cardiovascular Angiography and Interventions, and serves on the program committees of the ACC Scientific Sessions, the Transcatheter Cardiovascular Therapeutics conference, and the SCAI Scientific Sessions. He was the chairman of the 2017 ACC-i2 Summit and was the chair of the SCAI 2019 Annual Scientific Session. In addition, he was the Editor-in-Chief of the ACC CathSAP 5 program and is currently the co-chair of the ACC Collaborative Management Pathway for Interventional Cardiology.
His main research interests are pharmacological and interventional therapies for acute coronary syndromes, as well as bleeding and blood transfusion complications among patients with ischemic heart disease. Dr. Rao has published over 300 peer-reviewed papers, and is the co-Editor-in-Chief of the seminal textbook on transradial procedures titled “Best Practices for Transradial Approach in Diagnostic Angiography and Intervention.”
Show Less
Add to calendar
Ron Waksman
Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital...
Read More
Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital Center (MWHC) and Director of Cardiovascular Research and Advanced Education for the MedStar Heart and Vascular Institute at the MedStar Washington Hospital Center. With nearly 20 years of experience in leading edge medical technologies, Dr. Waksman is a world-renowned interventional cardiologist and is a highly sought after Principal Investigator for pre-clinical and clinical studies conducted in the United States and abroad. Dr Waksman has performed over 5000 coronary interventions throughout his career.
Show Less
Add to calendar
Farouc Jaffer
Dr. Farouc Jaffer graduated from Stanford University in 1990 with a B.S. in Mathematical and...
Read More
Dr. Farouc Jaffer graduated from Stanford University in 1990 with a B.S. in Mathematical and Computational Sciences, and received in MD and PhD in Biophysics from the University of Pennsylvania of Medicine in 1996. He completed a residency in internal medicine at the Brigham and Women's Hospital, followed by a fellowship in cardiovascular medicine and interventional cardiology at Massachusetts General Hospital. In 2003, he joined the Cardiology Division as faculty.
Dr. Jaffer is currently an Associate Professor of Medicine at Harvard Medical School and an Attending Interventional Cardiologist at Massachusetts General Hospital. He is Director of Coronary Intervention and Director of the Chronic Total Occlusion (CTO) PCI Program at at Massachusetts General Hospital. The MGH is a leading center for treating the most complex coronary blockages, such as CTO. Many patients, previously without options, have successfully underwent CTO PCI, and have experienced marked reductions in angina (chest pain) and shortness of breath.
Dr. Jaffer is also a Principal Investigator in the MGH Cardiovascular Research Center where his NIH-funded laboratory develops novel molecular imaging approaches to image high-risk plaques and blood clots, to better prevent heart attacks, strokes, and venous blood clots.
Show Less
Add to calendar
• Malapposition matters
• Expansion matters more
• Q&A with Panel Discussion
Hiram Bezerra
Hiram Bezerra, MD, PhD, is Director, Cardiovascular Imaging Core Laboratory as well as Director,...
Read More
Hiram Bezerra, MD, PhD, is Director, Cardiovascular Imaging Core Laboratory as well as Director, Director, Advanced Coronary and MCS at University Hospital Cleveland Medical Center. He is also an Associate Professor, Medicine at Case Western Reserve University School of Medicine. Previously, he served at Massachusetts General Hospital with extensive expertise in Cardiac Imaging, Interventional Cardiology, Optical Coherence Tomography and Computed Tomography.
Show Less
Paul Teirstein
Paul Teirstein, MD, is the Chief of Cardiology and Director of Interventional Cardiology for...
Read More
Paul Teirstein, MD, is the Chief of Cardiology and Director of Interventional Cardiology for Scripps Clinic and Director of the Scripps Prebys Cardiovascular Institute for Scripps Health. With a primary focus on complex coronary interventions and new technology development, Dr. Teirstein has played an active role in the initial development and clinical investigation of coronary stent procedures, rotablator atherectomy, coronary angioscopy and the utilization of cardiopulmonary support. Dr. Teirstein pioneered the first effective treatment for restenosis (low dose radiation therapy) and was one of the early investigators of medicated and bioabsorbable stents. Recent areas of investigation include new technology for minimally invasive transcatheter aortic valve replacement (TAVR). Dr. Teirstein currently performs in excess of 800 stent procedures per year and maintains an active clinical research and teaching unit at Scripps Clinic where he strives to offer patients the most advanced cardiovascular care available worldwide.
Show Less
Add to calendar
Ki Park
Ki Park, MD, is a clinical assistant professor of medicine in interventional cardiology. In...
Read More
Ki Park, MD, is a clinical assistant professor of medicine in interventional cardiology. In addition to her professorship role, she is the director of women’s cardiovascular health at UF Health.
Dr. Park received a bachelor’s degree in microbiology at the University of Florida. She also completed her internal medicine residency, general cardiology fellowship and interventional cardiology fellowship at the University of Florida College of Medicine. During her fellowship training, she also completed a Cardiovascular Cell Therapy Research Network Fellowship and earned a master of science in translational science through the APPCI program. In 2010, she received the UF Department of Medicine’s Excellence in Research Award as well as the American Heart Association’s Women in Cardiology Trainee Award for Excellence.
Dr. Park partners with other UF Health cardiologists to create a dedicated team for targeted cardiovascular women’s care in Gainesville and throughout Florida. She has a number of research studies focused on women-specific cardiology care to help offer the latest technologies and research to her patients.
Show Less
Add to calendar
Live Case Moderator: Jeffrey Moses, George Dangas
Panelists: George Petrossian, Newell Robinson, Kathleen Kearny, Kevin Croce
Allen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read More
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show Less
Richard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read More
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show Less
Add to calendar
Robert Riley
Dr. Riley is an Interventional Cardiologist specializing in the care of patients with complex and...
Read More
Dr. Riley is an Interventional Cardiologist specializing in the care of patients with complex and high-risk coronary artery disease and cardiogenic shock. He focuses on the treatment of coronary chronic total occlusions, multivessel coronary artery disease (including patients turned down for CABG surgery), atherectomy, and those in need of mechanical circulatory support.
He was born in Knoxville, TN and completed his undergraduate education at Furman University with a degree in Chemistry. He attended medical school at the University of Virginia and completed residency in Internal Medicine at the University of Washington. He then completed his Cardiology fellowship at Wake Forest University, during which he obtained a Masters degree in Clinical and Population Translational Science. He then returned to the University of Washington to complete his Interventional Cardiology fellowship, followed by the first ever advanced fellowship in Complex, High-Risk, and Indicated PCI and Hemodynamic Support before joining the group at Christ Hospital. He is very active in clinical research, co-edits a monthly newsletter on high-risk PCI, and enjoys speaking at national and international meetings.
Show Less
Add to calendar
Live Case Moderator: Jeffrey Moses, George Dangas
Panelists: George Petrossian, Newell Robinson, Kathleen Kearny, Kevin Croce
Allen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read More
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show Less
Ziad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read More
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show Less
Add to calendar
Morton Kern
Dr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine,...
Read More
Dr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine, University California, Irvine. He continues to perform and teach cardiac catheterization and PCI. Dr. Kern is ABIM Certified in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology and is a past president and now a Master Fellow of the SCAI. His research interests in coronary blood flow, intravascular physiology, intravascular ultrasound, vulnerable plaque and evaluation of cardiovascular hemodynamics. He has authored several textbooks, notably The Cardiac Catheterization Handbook, 6th ed. and its companion The Interventional Cardiac Cath Handbook, 4th ed.
Show Less
Add to calendar
Dr. William Fearon
Dr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia...
Read More
Dr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Cardiology and Director of Interventional Cardiology at Stanford University School of Mediciner. Dr. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology, the American Heart Association, and the Society of Cardiovascular Angiography and Interventions. He has been elected to the American Society for Clinical Investigation. Dr. Fearon’s primary area of research interest is in coronary physiology. He was the US principal investigator and senior author of the FAME trial, published in the New England Journal of Medicine and was a co-principal investigator and senior author of the FAME 2 trial, also published in the New England Journal of Medicine. He is now the principal investigator of the international FAME 3 trial comparing bypass surgery to fractional flow reserve guided percutaneous coronary intervention. He serves on the editorial board of the Journal of the American College of Cardiology, Circulation, JACC Cardiovascular Interventions, and Circulation: Cardiovascular Interventions. He was the principal investigator on an R01 and is the PI on an R61/R33 NIH award evaluating cardiac allograft vasculopathy early after transplantation. Dr. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement. He was a coauthor on the PARTNER 2A Trial published in the New England Journal of Medicine.
Show Less
Add to calendar
• Lessons from the ISCHEMIA trial – Spot stent for symptoms
• Lessons from the ISCHEMIA trial – Cover the plaque for better outcomes
• Q&A with Panel Discussion
Add to calendar
Add to calendar
Dimitri Karmpaliotis
Director of Rescue the Heart Program, Director CTO, and Advanced Coronary Therapeutics,...
Read More
Director of Rescue the Heart Program, Director CTO, and Advanced Coronary Therapeutics, Morristown Medical Center
Dimitrios Karmpaliotis, MD, PhD, FACC, FSCAI is Medical Director of the Cardiovascular Rescue and Recovery Program and the Advanced Coronary Therapeutics and Chronic Total Occlusions Program at Morristown Medical Center. Dr. Karmpaliotis was formerly at the Center for Interventional Vascular Therapy at Columbia University Medical Center, where he provided world-class care since 2014. He is a former associate professor of medicine at Columbia University Medical School and formerly served as director of the Chronic Total Occlusions, Complex and High-Risk Angioplasty Program at New York-Presbyterian/Columbia University Medical Center.
Show Less
Add to calendar
David Kandzari
Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service...
Read More
Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology of the Piedmont Heart Institute; and Chief Scientific Officer for Piedmont Healthcare in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences.
Dr. Kandzari is the former Director of Interventional Cardiology Research at the Scripps Clinic in La Jolla, California. Before joining the Scripps faculty, he also served as Chief Medical Officer for the Cordis Corporation, a Johnson & Johnson Company. He has also served as a Medical Officer for the Center for Devices and Radiological Health for the United States Food and Drug Administration. Board certified by the American Board of Internal Medicine and its subspecialty Board of Cardiovascular Disease and Board of Interventional Cardiology, Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 400 studies, book chapters and scientific reviews, and has delivered more than 700 lectures, both nationally and internationally, on a variety of issues related to both interventional and general cardiology.
Dr. Kandzari has been consecutively voted as one of Atlanta's Top Doctors by Atlanta Magazine from 2011 to 2021, and is peer-nominated in the top 1% of cardiologists by U.S News and World Report.
Show Less
Add to calendar
Stéphane Rinfret
Dr Stéphane Rinfret is an academic interventional cardiologist and world-renown expert in chronic...
Read More
Dr Stéphane Rinfret is an academic interventional cardiologist and world-renown expert in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). He was appointed chief of interventional cardiology at the McGill University Health Centre (MUHC) and associate professor of medicine at McGill University in 2016 where he built a very active chronic total occlusion (CTO) and Complex Higher-risk but Indicated Procedures (CHIP) program. He has now moved to the US to work with at Emory Healthcare and Emory University, as associate-director of complex PCI and full professor (acting) of Medicine, to pursue his academic career and busy clinical practice, mostly at Emory Saint Joseph's Hospital, the oldest hospital of Atlanta serving a very large population. Dr Rinfret has held several peer-reviewed grants, published over 150 peer-reviewed articles, several abstracts, and has been invited over 300 times to give lectures in the last 10 years. His epidemiological research focuses on health services and outcomes. He is also a high-volume and world-renown coronary operator, performing over 400 percutaneous coronary interventions (PCIs) per year, mostly from the transradial approach and most with complex anatomies. Dr Rinfret was one of the Canadian pioneers in CTO PCI and has contributed to expand access to the technique in Canada and all around the world through sharing his expertise. He is the lead editor of a textbook on CTO PCI published by Springer in 2015, currently being reviewed for a second edition. He has performed over 1200 CTO PCIs since January 2010, one of the largest volumes in the world, including a large number of retrograde procedures, and pursues a very active teaching program of transradial and CTO PCI techniques in Canada and Europe.
Show Less
Add to calendar
• Optimal Bifurcation PCI – A provisional 2-stent strategy is the strategy of choice
• Optimal Bifurcation PCI – A planned 2-stent strategy - don’t hesitate!
• Q&A with Panel Discussion/Wrap-up
Azeem Latib
Works at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical....
Read More
Works at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical. Azeem Latib generally speaks on Bioresorbable Vascular Scaffold (BVS), Drug Eluting Stents (DES), Intravascular Ultrasound (IVUS), Bifurcation, and Intracoronary Imaging.
Show Less
Michael Lee
Dr. Michael S. Lee, is an interventional cardiologist, Associate Professor of Medicine and the...
Read More
Dr. Michael S. Lee, is an interventional cardiologist, Associate Professor of Medicine and the Associate Director of Interventional Cardiology Research at the UCLA Medical Center. Dr. Lee has published over 110 (over 70 of which were as first author) peer reviewed articles and chapters. He has also published on topics including antithrombotic therapy in patients with acute coronary syndrome and in percutaneous coronary intervention, protocols to establish heparin dosing regimens, and percutaneous coronary intervention for the treatment of left main disease, saphenous vein grafts, and cardiac allograft vasculopathy who have undergone orthotopic heart transplantation. He is one of the world’s authorities in coronary and peripheral orbital atherectomy.
Show Less
Add to calendar
Jeffrey Moses
An internationally recognized interventional cardiologist, Dr. Moses has performed more than...
Read More
An internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.
Show Less
Add to calendar
Elazer Edelman
Elazer Edelman works at MIT, Boston, MA, USA.
Read More
Elazer Edelman works at MIT, Boston, MA, USA.
Show Less
Add to calendar
Ori Ben-Yehuda
Ori Ben-Yehuda, is the Executive Director of the Clinical Trials Center at the Cardiovascular...
Read More
Ori Ben-Yehuda, is the Executive Director of the Clinical Trials Center at the Cardiovascular Research Foundation. A graduate of Tel Aviv University, he completed his fellowship in cardiology at the University of California, San Diego. From 1997 to 2011 he was the Director of the Coronary Care Unit at UCSD where he was also Professor of Medicine. He also served as the Deputy Editor of the Journal of the American College of Cardiology and is presently the Deputy Editor of Structural Heart: the Journal of the Heart Team. Dr. Ben-Yehuda is involved in the design and execution of multiple clinical trials in interventional cardiology.
Show Less
Add to calendar
Manesh Patel
Manesh Patel is the Chief of the Division of Cardiology and the Division of Clinical...
Read More
Manesh Patel is the Chief of the Division of Cardiology and the Division of Clinical Pharmacology. His clinical interests include diagnostic and interventional coronary angiography, peripheral angiography and endovascular intervention. His is involved in several clinical trials involving patients with cardiovascular disease and in cardiac imaging. He is also the Chair of the American College of Cardiology Task Force for Appropriate Use Criteria for Cardiovascular Procedures and is Chair of the American Heart Association Diagnostic and Interventional Cath Committee.
Patel's interest in cardiac imaging, quality of care, cardiac devices is also evident in his research. His integration of these efforts into his roles at Duke was recognized in 2010 when he received the prestigious Duke Cardiology Fellowship Mentor Award. In 2011, Dr. Patel was named the endowed John Bush Simpson Assistant Professor of Cardiology. In 2013, Dr. Patel received the Robert M. Califf Faculty clinical research Award.
Currently, Dr. Patel is leading an effort to redesign the delivery of care to patients undergoing invasive catheterization procedures in the health system with a specific aim of measure and providing individualized, patient centered, innovative, and efficient care.
Show Less
Add to calendar
Add to calendar
Add to calendar
• Vulnerable plaque detection will revolutionize coronary prevention
• Vulnerable plaque detection is a pipe-dream
• Q&A with Panel Discussion
Gary Mintz
Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF,...
Read More
Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF, New York, NY) and a Director of Transcatheter Cardiovascular Therapeutics (TCT). He is the author of more than 1000 peer reviewed articles, 60 book chapters, 4 books, and 850 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and (especially) intravascular imaging and physiology. In 2005, Dr. Mintz published his single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese. In 2014, Dr. Mintz received the Master of the Masters Career Achievement Award at the TCTAP-Cardiovascular Summit in Seoul, Korea; in 2015 Dr. Mintz received the Chien Foundation Outstanding Lectureship & Lifetime Achievement Award, also presented at TCTAP-Cardiovascular Summit in Seoul, Korea; in 2017 Dr. Mintz received the Outstanding Achievement Award at CBS 2017, Nanjing, China; in 2018 Dr. Mintz received the Career Achievement Award at NFIC in Krakow, Poland; and in 2020 Dr. Mintz received the Jiangsu Friendship Award from the People’s Government of Jiangsu Province, China, the highest award presented to a non-Chinese. He also serves as a Senior Scientist and Advisor at the Medstar Cardiovascular Research Network, Washington, DC. Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University (now part of Drexel University), in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty in 1978 and was ultimately promoted to Professor of Medicine in 1987 before joining CRF in 1991. His past appointments at CRF have included Chief Medical Officer and Editor-in-Chief (and one of the founders) of TCTMD.com.
Show Less
Juan Granada
Works at CRF Skirball Center for Innovation, Orangeburg, NY, USA. Features in 13 videos on Wondr...
Read More
Works at CRF Skirball Center for Innovation, Orangeburg, NY, USA. Features in 13 videos on Wondr Medical. Juan Granada generally speaks on Mitral, Repair/Replacement, Trans Mitral Valve Implantation (TMVR), Mitral regurgitation, and Bioresorbable Vascular Scaffold (BVS).
Show Less
Add to calendar
Allen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read More
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show Less
David Cohen
David J. Cohen, MD, MSc is currently Director of Clinical and Outcomes Research at the...
Read More
David J. Cohen, MD, MSc is currently Director of Clinical and Outcomes Research at the Cardiovascular Research Foundation (New York, NY) and Director of Academic Affairs at St. Francis Hospital (Roslyn, NY). Previously, he was Professor of Medicine at the University of Missouri–Kansas City and Director of Cardiovascular Research and Medical Director of Health Economics and Technology Assessment at Saint Luke’s Mid America Heart Institute. Heart Institute where he continues to direct the Health Economics and Technology Assessment Group. Dr. Cohen earned his M.D. at Harvard Medical School and his Master's degree in Health Policy at the Harvard School of Public Health. He did his clinical training at Brigham and Women's Hospital and was a clinical and research fellow in cardiology at Beth Israel Hospital for five years.
Dr. Cohen is a practicing interventional cardiologist with a focus on structural and valvular heart disease. His research focuses on the application of formal cost-effectiveness methodology to novel interventions for cardiovascular disease (CVD), the extension of traditional cardiovascular outcomes research to include patient-centered outcomes, and the development and evaluation of instruments for assessing CVD patients’ health status and preferences. He is also active in research to determine the short- and long-term outcomes of new devices for percutaneous coronary revascularization and identifying the optimal target populations and techniques for these devices.
Dr. Cohen has published more than 500 original articles in leading journals, including the New England Journal of Medicine, Lancet, JAMA, Circulation, and the Journal of the American College. Dr. Cohen serves on the editorial board for the American Heart Journal, JACC Interventions, and Circulation and reviews for the American Journal of Cardiology, Journal of the American College of Cardiology, New England Journal of Medicine, JAMA, and Medical Decision Making.
Show Less
Evan Shlofmitz
Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at...
Read More
Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at St. Francis Hospital - The Heart Center in Roslyn, NY. He completed a fellowship in Interventional Cardiology at Georgetown University/MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC), a Cardiovascular Disease fellowship at Northwell Health and served as Chief Resident for Internal Medicine at New York Presbyterian Queens. He serves on SCAI's IHD Council and is a co-director of Optimizing PCI (OPCI). His research interests have centered on intravascular imaging, the treatment of calcified coronary artery disease, in-stent restenosis and the optimization of stent implantation, with more than 100 publications in peer-reviewed journals.
Show Less
Jeffrey Moses
An internationally recognized interventional cardiologist, Dr. Moses has performed more than...
Read More
An internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.
Show Less
Richard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read More
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show Less
Ziad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read More
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show Less
Add to calendar
Richard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read More
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show Less
Add to calendar
World-leading experts will review relevant trial data, and discuss advancements in device concepts.
World-leading experts will review relevant trial data, and discuss advancements in device concepts.
Robert Busch
Dr. Robert Busch, MD, practices Endocrinology, Diabetes, & Metabolism in Albany, NY at Endocrine...
Read MoreDr. Robert Busch, MD, practices Endocrinology, Diabetes, & Metabolism in Albany, NY at Endocrine Group. Dr. Robert Busch received his B.A. from Brandeis University,and his Medical Degree from the University of Pennsylvania. He served his Internship, Residency,and was Chief Medical Resident at North Shore University Hospital,prior to his endocrinology fellowship at Albany Medical College.
Show LessSGLT2 Inhibitors: A drug for Heart Failure, Diabetes or Renal disease? One Drug that does it all
Rita Jermyn
Dr Jermyn is the director of the center for advanced cardiac therapeutics at st francis hospital....
Read MoreDr Jermyn is the director of the center for advanced cardiac therapeutics at st francis hospital. She also holds an appointment as an assistant professor at the Albert Einstein College of Medicine where she completed her advanced heart failure and transplant fellowship. Her research interests include ambulatory pulmonary artery pressure monitoring, cardiometabolic syndrome, and mechanical circulatory support. She is board certified in cardiology and heart failure.
Show LessBalancing ischemic and bleeding risk: Contemporary use of anti-platelet and anti-thrombotic therapy following PCI
Darshan Doshi
Dr. Darshan Doshi is an interventional cardiologist at the Massachusetts General Hospital who...
Read MoreDr. Darshan Doshi is an interventional cardiologist at the Massachusetts General Hospital who specializes in complex coronary interventions. He also helps directs the chronic total occlusions program, and leads imaging and physiology efforts in the cath lab. Dr. Doshi received his BA from Columbia University’s Columbia College and his MD from Columbia University’s College of Physicians and Surgeons. He completed his internal medicine residency, and his cardiovascular medicine and interventional cardiology fellowships at the Columbia University Medical Center. Dr. Doshi also underwent additional dedicated training at Columbia in complex and high-risk interventional procedures. He was then recruited to join the faculty in the Division of Cardiology at the Massachusetts General Hospital. Dr. Doshi also holds a MS in patient-oriented research from Columbia University’s Mailman School of Public Health with a research interest focused on clinical trials evaluating novel cardiovascular devices and therapeutics in interventional cardiology. He has authored several original manuscripts in translational and clinical cardiovascular medicine, and has published in the New England Journal of Medicine, Lancet, Journal of the American College of Cardiology, and Circulation, among many others.
Show LessRichard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read MoreDr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show LessJennifer Tremmel
An interventional cardiology at Stanford University Medical Center, Stanford, CA, USA. Features...
Read MoreAn interventional cardiology at Stanford University Medical Center, Stanford, CA, USA. Features in 2 videos on Wondr Medical. Jennifer Tremmel generally speaks on Coronary Interventions, Structural Cardiac Interventions, Microvascular Disease (MVD), and Stable Coronary Artery Disease (CAD).
Show LessOlga Toleva
Dr. Olga Toleva graduated Medicine in Sofia, Bulgaria, and completed Family Medicine residency at...
Read MoreDr. Olga Toleva graduated Medicine in Sofia, Bulgaria, and completed Family Medicine residency at the University of British Columbia, Vancouver, Canada. She subsequently practiced as a Family physician and after a year in practice entered the Internal Medicine residency program at UBC, Vancouver. Dr. Toleva completed her training in Adult Cardiology and Interventional cardiology at the University of Alberta, Edmonton, Canada. During her cardiology fellowship she also completed Masters in Public Health at The Harvard School of Public Health. Dr. Toleva worked as an Assistant Professor in the University of Manitoba and an Interventional Cardiologist at St. Boniface Hospital from 2014 until March 2021. She was involved in Transcatheter Aortic Valve Replacement (TAVR) and coronary physiology. She focused on outcomes research, frailty, and quality of life assessments in the older adults who are the predominant population requiring TAVR. Dr. Olga Toleva just moved to the US and is a new Interventional Cardiologist at Emory Healthcare, primarily located at Emory St. Joseph's Hospital. She is involved in Transcatheter Aortic Valve Replacement (TAVR) and coronary physiology microvascular dysfunction invasive testing in the cardiac catheterization laboratory. Dr. Toleva has a strong interest in Women's Heart Health with clinical work and research related to the diagnosis and therapy of Spontaneous Coronary Artery Dissection (SCAD), Myocardial infarction without obstructive coronary artery disease (MINOCA), and Micro Vascular Dysfunction (MVD) - chest pain syndromes without obstructive coronary disease. She will be part of the Emory Women's Heart Health Clinic focusing on the care of patients and performing research in the area. These conditions are predominantly seen in women and continue to be poorly understood and under-treated. Dr. Toleva has a high volume PCI and TAVR practice and is very active in the world of coronary and structural heart research and innovation.
Show LessAllen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read MoreAllen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show LessMartin Leon
Martin B. Leon, MD is Professor of Medicine at Columbia University Irving Medical Center (CUIMC)....
Read MoreMartin B. Leon, MD is Professor of Medicine at Columbia University Irving Medical Center (CUIMC). Dr. Leon is also Director of Columbia Interventional Cardiovascular Care, Director of the Cardiac Catheterization Laboratories, and is on the Executive Board of the Columbia Structural Heart & Valve Center. He is a practicing interventional cardiologist at NewYork-Presbyterian Hospital in New York City. Dr. Leon is also the Founder and Chairman Emeritus of the Cardiovascular Research Foundation. Dr. Leon has served as principal investigator for over 50 clinical trials that have helped shape the field of interventional cardiovascular medicine, including the following studies: STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis. Dr. Leon has co-authored over 1550 publications, has performed over 10,000 interventional procedures, and has had a major impact as a thought-leader and innovator in the expanding sub-specialty of interventional cardiovascular device and drug therapies. He is the Director and Founder of Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier interventional cardiovascular meeting, which recently celebrated its 24th anniversary. Dr. Leon has also served as Director or Co-Director of more than 100 international educational programs in areas of interventional cardiology. Dr. Leon has received 10 international career achievement awards and was awarded an honorary degree from the University of Athens.
Show LessZiad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read MoreZiad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show Less-
Which drugs when in CMD - Bruce Samuels
-
Call it what you want, it’s all just GDMT - Duane Pinto
- Q&A with Panel Discussion
Bruce Samuels
Dr. Bruce Samuels is an interventional cardiologist on staff at Cedars-Sinai Medical Center...
Read MoreDr. Bruce Samuels is an interventional cardiologist on staff at Cedars-Sinai Medical Center (CSMC) in Los Angeles, California. Dr. Samuels completed his medical studies at Albert Einstein College of Medicine in New York before returning to Southern California to complete his residency and chief residency in Internal Medicine at Harbor-UCLA Medical Center. At CSMC, he trained in both general and interventional cardiology before joining the medical staff there. In addition to his clinical practice in coronary intervention, Dr. Samuels has actively participated in numerous interventional trials including IVUS guided therapy, coronary physiology and microvascular disease. He is also working closely with the Barbra Streisand Women’s Heart Center based at CSMC, working as an interventionalist in the active coronary reactivity research there. As co-chair of a 30-day readmissions task force, he has helped to shape policy for CSMC in its efforts to improve quality delivery of care. He has frequently been invited as faculty to many scientific meetings and is a sought after speaker for numerous peer educational platforms. Dr. Samuels is a fellow of the American College of Cardiology and is Board Certified in Internal Medicine, Cardiovascular Diseases, and Interventional Cardiology. He is married with three sons; his outside interests include contemporary art and long distance running.
Show LessDuane Pinto
Dr. Pinto received his B.A., cum Laude, from Dartmouth College in Hanover, NH and M.D. degree...
Read MoreDr. Pinto received his B.A., cum Laude, from Dartmouth College in Hanover, NH and M.D. degree from the Georgetown University, cum Laude and Alpha Omega Alpha. He was an Intern, Resident, Chief Resident, General Cardiology Fellow and Interventional Cardiology Fellow at Harvard Medical School and Beth Israel Hospital, Boston, MA. Dr. Pinto is an Associate Professor of Medicine at Harvard Medical School and serves as the Director of the Cardiac Intensive Care Unit, Associate Chief of the Interventional Section and Director of the General Cardiology Fellowship Program at Beth Israel Deaconess Medical Center. He has been awarded cardiology fellow teaching and mentorship awards from Harvard Medical School. His clinical expertise is in general and interventional cardiology. In addition to a busy outpatient practice, he performs coronary and peripheral angioplasty and stenting procedures. These include stenting and other procedures in the heart, leg, abdominal and neck arteries. Dr. Pinto has research interests in a wide variety of topics including acute myocardial infarction studies, unstable angina studies, interventional trials, peripheral interventional trials specializing in clinical outcome, comparative effectiveness and cost-effectiveness studies. Dr. Pinto is the editor of the Controversies in Cardiology section for Circulation. He is a manuscript reviewer for the New England Journal, Circulation and the Journal of the American College of Cardiology. He has published over 75 articles in journals such as The New England Journal of Medicine, Circulation, Journal of the American College of Cardiology and JAMA. His work highlights the management and outcomes of patients with cardiac and vascular disorders.
Show LessHector Garcia-Garcia
Hector M. Garcia-Garcia, MD, PhD, is now serving as an attending cardiologist for MedStar Heart &...
Read MoreHector M. Garcia-Garcia, MD, PhD, is now serving as an attending cardiologist for MedStar Heart & Vascular Institute and director of the Coronary Invasive Imaging Core Lab. Prior to joining the MHVI medical staff, Dr. Garcia-Garcia served as Director of the Core Lab of Invasive Imaging at Cardialysis—a leading cardiology clinical research organization—and as researcher at the Erasmus Medical Center in Rotterdam, The Netherlands and Inselspital in Bern, Switzerland. He received both a Master’s and Doctorate degree from the Erasmus University of Rotterdam. An accomplished researcher, Dr. Garcia-Garcia has widely published in many international medical journals (more than 530 publications - H-index of 61), authored book chapters in most renowned cardiovascular textbooks and has presented at cardiology conferences world-wide. He is an expert in innovative cardiovascular technology. He has mentored seven PhD students and published their thesis.
Show LessKhady Fall
A physiology manager at Columbia University Medical Center, NY, US. Features in 1 video on Wondr...
Read MoreA physiology manager at Columbia University Medical Center, NY, US. Features in 1 video on Wondr Medical. Khady Fall generally speaks on Intravascular Ultrasound (IVUS) and Coronary Optical Coherence Tomography (OCT).
Show LessHabib Samady
Dr Habib Samady is an interventional cardiologist and serves as President of the Georgia Heart...
Read MoreDr Habib Samady is an interventional cardiologist and serves as President of the Georgia Heart Institute, the heart and vascular program of Northeast Georgia Health System. He is also Director of the Georgia Center for Cardiovascular Biomechanics and Modeling and Adjunct Professor of Medicine at Emory University. Dr Samady is recognized as one of the foremost international experts in coronary physiology. He earned his medical degree from the University of Sheffield in England, and completed his residency training in both London and in Sheffield. He subsequently completed an internal medicine residency and chief residency at the University of Connecticut, before his fellowship in general cardiology, nuclear cardiology, and interventional cardiology at Yale University in Connecticut.
Show LessAkiko Maehara
Dr.Akiko Maehara is a Professor at Columbia University Medical Center and work as a Director of...
Read MoreDr.Akiko Maehara is a Professor at Columbia University Medical Center and work as a Director of Intravascualr Imaging and MRI Core Laboratories at Cardiovascular Research Foundation In New York. She is an expert of intravascular imging (Intraascular ultrasound, Optical coherence tomography, Infrared spectroscopy) to detect vulnerable plauqe and optimize PCI.
Show Less-
It’s all about the flow – Why physiology guided PCI should be the standard - Ajay Kirtane
-
It’s all about the plaque–Why imaging rules it all - Gregg Stone
-
Q&A with Panel Discussion
- Stump the Panel–Unusual Left Main Cases - Rapid Fire - Gary Mintz
Gary Mintz
Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF,...
Read MoreGary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF, New York, NY) and a Director of Transcatheter Cardiovascular Therapeutics (TCT). He is the author of more than 1000 peer reviewed articles, 60 book chapters, 4 books, and 850 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and (especially) intravascular imaging and physiology. In 2005, Dr. Mintz published his single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese. In 2014, Dr. Mintz received the Master of the Masters Career Achievement Award at the TCTAP-Cardiovascular Summit in Seoul, Korea; in 2015 Dr. Mintz received the Chien Foundation Outstanding Lectureship & Lifetime Achievement Award, also presented at TCTAP-Cardiovascular Summit in Seoul, Korea; in 2017 Dr. Mintz received the Outstanding Achievement Award at CBS 2017, Nanjing, China; in 2018 Dr. Mintz received the Career Achievement Award at NFIC in Krakow, Poland; and in 2020 Dr. Mintz received the Jiangsu Friendship Award from the People’s Government of Jiangsu Province, China, the highest award presented to a non-Chinese. He also serves as a Senior Scientist and Advisor at the Medstar Cardiovascular Research Network, Washington, DC. Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University (now part of Drexel University), in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty in 1978 and was ultimately promoted to Professor of Medicine in 1987 before joining CRF in 1991. His past appointments at CRF have included Chief Medical Officer and Editor-in-Chief (and one of the founders) of TCTMD.com.
Show LessGeorge Dangas
Works at The Mount Sinai Hospital, New York, NY, USA. Features in 3 videos on Wondr Medical....
Read MoreWorks at The Mount Sinai Hospital, New York, NY, USA. Features in 3 videos on Wondr Medical. George Dangas generally speaks on Cardiovascular Pharmacotherapy, Acute Coronary Syndromes (ACS), Primary Percutaneous Coronary Intervention (PPCI), Transcatheter Aortic Valve Implantation (TAVR / TAVI), and Coronary Physiology.
Show LessGregg Stone
Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic...
Read MoreGregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 120 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. With a 2018 H-factor of 152, Dr. Stone was recently listed in Nature Medicine as one of the most prolific authors in science. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes, myocardial infarction and cardiogenic shock; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter valve repair and replacement; interventional hypertension and heart failure therapies; left atrial appendage closure; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; adjunctive interventional devices including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; contrast nephropathy; clinical trial design; and regulatory issues. Dr. Stone is the director of TCT, the world's largest symposium devoted to interventional cardiology and vascular medicine. Dr. Stone founded the annual National Interventional Cardiology Fellow's Course and Transcatheter Valve Therapies TVT), the Chronic Total Occlusion (CTO) Summit, and co-directs multiple other meetings in the US, China, Russia, Europe, S. Korea and elsewhere.
Show LessRony Mathew
A senior consultant & interventional cardiologist at Lisie Heart Institute, Kochi, India....
Read MoreA senior consultant & interventional cardiologist at Lisie Heart Institute, Kochi, India. Features in 1 video on Wondr Medical. Rony Mathew generally speaks on Coronary Optical Coherence Tomography (OCT) and Bifurcation.
Show LessS Ajit Mullasari
A director of cardiology at The Institute of Cardio-Vascular Diseases, Madras Medical Mission,...
Read MoreA director of cardiology at The Institute of Cardio-Vascular Diseases, Madras Medical Mission, Chennai, India. Features in 2 videos on Wondr Medical. S Ajit Mullasari generally speaks on Fractional Flow Reserve (FFR), Instantaneous wave-Free Ratio (iFR), Coronary Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS), and Rotational Atherectomy (PVD).
Show LessBalbir Singh
A chairman of interventional cardiology at Medanta Medicity Hospital, Gurgaon, India. Features in...
Read MoreA chairman of interventional cardiology at Medanta Medicity Hospital, Gurgaon, India. Features in 1 video on Wondr Medical. Balbir Singh generally speaks on Coronary Optical Coherence Tomography (OCT) and Left Main Stem (LMS).
Show LessJasvindar Singh
Dr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization...
Read MoreDr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization Laboratory at Barnes-Jewish Hospital and Director of Interventional Cardiology. He specializes in coronary and peripheral vascular interventional procedures and spends most of his time in the cardiac catheterization laboratory. His expertise is in complex coronary intervention and also the endovascular treatment of renovascular hypertension, and peripheral arterial occlusive diseases. In addition, he has been involved in research ranging from new coronary devices to intravascular ultrasound and pressure/flow assessment of coronary vessels. He is the Principal Investigator in several high profile multicenter trials evaluating the above. He is actively involved in resident/fellow education and rotate in the coronary care unit twice a year. He has two interventional fellows per year who work closely with him during their training, he also serves as their attending in ½ day in patient clinic. He has second and third year cardiology fellows involved in clinical research protocols in the cath lab and their work has produced three instrumental abstracts/papers which in the first 12 months were presented at major cardiovascular society meetings. Dr. Singh is also the Chairman of ARCH, one of the largest Midwest Interventional Symposium.
Show LessSunil Rao
Dr. Rao is Professor of Medicine at Duke University Medical Center, and the Section Chief of...
Read MoreDr. Rao is Professor of Medicine at Duke University Medical Center, and the Section Chief of Cardiology at the Durham VA Medical Center. At the national level, Dr. Rao serves as the Editor-in-Chief for Circulation Cardiovascular Interventions, the interventional journal of the American Heart Association’s flagship Circulation family of journals. He is the President-Elect for The Society for Cardiovascular Angiography and Interventions, and serves on the program committees of the ACC Scientific Sessions, the Transcatheter Cardiovascular Therapeutics conference, and the SCAI Scientific Sessions. He was the chairman of the 2017 ACC-i2 Summit and was the chair of the SCAI 2019 Annual Scientific Session. In addition, he was the Editor-in-Chief of the ACC CathSAP 5 program and is currently the co-chair of the ACC Collaborative Management Pathway for Interventional Cardiology. His main research interests are pharmacological and interventional therapies for acute coronary syndromes, as well as bleeding and blood transfusion complications among patients with ischemic heart disease. Dr. Rao has published over 300 peer-reviewed papers, and is the co-Editor-in-Chief of the seminal textbook on transradial procedures titled “Best Practices for Transradial Approach in Diagnostic Angiography and Intervention.”
Show LessRon Waksman
Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital...
Read MoreRon Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital Center (MWHC) and Director of Cardiovascular Research and Advanced Education for the MedStar Heart and Vascular Institute at the MedStar Washington Hospital Center. With nearly 20 years of experience in leading edge medical technologies, Dr. Waksman is a world-renowned interventional cardiologist and is a highly sought after Principal Investigator for pre-clinical and clinical studies conducted in the United States and abroad. Dr Waksman has performed over 5000 coronary interventions throughout his career.
Show LessFarouc Jaffer
Dr. Farouc Jaffer graduated from Stanford University in 1990 with a B.S. in Mathematical and...
Read MoreDr. Farouc Jaffer graduated from Stanford University in 1990 with a B.S. in Mathematical and Computational Sciences, and received in MD and PhD in Biophysics from the University of Pennsylvania of Medicine in 1996. He completed a residency in internal medicine at the Brigham and Women's Hospital, followed by a fellowship in cardiovascular medicine and interventional cardiology at Massachusetts General Hospital. In 2003, he joined the Cardiology Division as faculty. Dr. Jaffer is currently an Associate Professor of Medicine at Harvard Medical School and an Attending Interventional Cardiologist at Massachusetts General Hospital. He is Director of Coronary Intervention and Director of the Chronic Total Occlusion (CTO) PCI Program at at Massachusetts General Hospital. The MGH is a leading center for treating the most complex coronary blockages, such as CTO. Many patients, previously without options, have successfully underwent CTO PCI, and have experienced marked reductions in angina (chest pain) and shortness of breath. Dr. Jaffer is also a Principal Investigator in the MGH Cardiovascular Research Center where his NIH-funded laboratory develops novel molecular imaging approaches to image high-risk plaques and blood clots, to better prevent heart attacks, strokes, and venous blood clots.
Show Less• Expansion matters more
• Q&A with Panel Discussion
Hiram Bezerra
Hiram Bezerra, MD, PhD, is Director, Cardiovascular Imaging Core Laboratory as well as Director,...
Read MoreHiram Bezerra, MD, PhD, is Director, Cardiovascular Imaging Core Laboratory as well as Director, Director, Advanced Coronary and MCS at University Hospital Cleveland Medical Center. He is also an Associate Professor, Medicine at Case Western Reserve University School of Medicine. Previously, he served at Massachusetts General Hospital with extensive expertise in Cardiac Imaging, Interventional Cardiology, Optical Coherence Tomography and Computed Tomography.
Show LessPaul Teirstein
Paul Teirstein, MD, is the Chief of Cardiology and Director of Interventional Cardiology for...
Read MorePaul Teirstein, MD, is the Chief of Cardiology and Director of Interventional Cardiology for Scripps Clinic and Director of the Scripps Prebys Cardiovascular Institute for Scripps Health. With a primary focus on complex coronary interventions and new technology development, Dr. Teirstein has played an active role in the initial development and clinical investigation of coronary stent procedures, rotablator atherectomy, coronary angioscopy and the utilization of cardiopulmonary support. Dr. Teirstein pioneered the first effective treatment for restenosis (low dose radiation therapy) and was one of the early investigators of medicated and bioabsorbable stents. Recent areas of investigation include new technology for minimally invasive transcatheter aortic valve replacement (TAVR). Dr. Teirstein currently performs in excess of 800 stent procedures per year and maintains an active clinical research and teaching unit at Scripps Clinic where he strives to offer patients the most advanced cardiovascular care available worldwide.
Show LessKi Park
Ki Park, MD, is a clinical assistant professor of medicine in interventional cardiology. In...
Read MoreKi Park, MD, is a clinical assistant professor of medicine in interventional cardiology. In addition to her professorship role, she is the director of women’s cardiovascular health at UF Health. Dr. Park received a bachelor’s degree in microbiology at the University of Florida. She also completed her internal medicine residency, general cardiology fellowship and interventional cardiology fellowship at the University of Florida College of Medicine. During her fellowship training, she also completed a Cardiovascular Cell Therapy Research Network Fellowship and earned a master of science in translational science through the APPCI program. In 2010, she received the UF Department of Medicine’s Excellence in Research Award as well as the American Heart Association’s Women in Cardiology Trainee Award for Excellence. Dr. Park partners with other UF Health cardiologists to create a dedicated team for targeted cardiovascular women’s care in Gainesville and throughout Florida. She has a number of research studies focused on women-specific cardiology care to help offer the latest technologies and research to her patients.
Show LessPanelists: George Petrossian, Newell Robinson, Kathleen Kearny, Kevin Croce
Allen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read MoreAllen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show LessRichard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read MoreDr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show LessRobert Riley
Dr. Riley is an Interventional Cardiologist specializing in the care of patients with complex and...
Read MoreDr. Riley is an Interventional Cardiologist specializing in the care of patients with complex and high-risk coronary artery disease and cardiogenic shock. He focuses on the treatment of coronary chronic total occlusions, multivessel coronary artery disease (including patients turned down for CABG surgery), atherectomy, and those in need of mechanical circulatory support. He was born in Knoxville, TN and completed his undergraduate education at Furman University with a degree in Chemistry. He attended medical school at the University of Virginia and completed residency in Internal Medicine at the University of Washington. He then completed his Cardiology fellowship at Wake Forest University, during which he obtained a Masters degree in Clinical and Population Translational Science. He then returned to the University of Washington to complete his Interventional Cardiology fellowship, followed by the first ever advanced fellowship in Complex, High-Risk, and Indicated PCI and Hemodynamic Support before joining the group at Christ Hospital. He is very active in clinical research, co-edits a monthly newsletter on high-risk PCI, and enjoys speaking at national and international meetings.
Show LessPanelists: George Petrossian, Newell Robinson, Kathleen Kearny, Kevin Croce
Allen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read MoreAllen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show LessZiad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read MoreZiad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show LessMorton Kern
Dr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine,...
Read MoreDr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine, University California, Irvine. He continues to perform and teach cardiac catheterization and PCI. Dr. Kern is ABIM Certified in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology and is a past president and now a Master Fellow of the SCAI. His research interests in coronary blood flow, intravascular physiology, intravascular ultrasound, vulnerable plaque and evaluation of cardiovascular hemodynamics. He has authored several textbooks, notably The Cardiac Catheterization Handbook, 6th ed. and its companion The Interventional Cardiac Cath Handbook, 4th ed.
Show LessDr. William Fearon
Dr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia...
Read MoreDr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Cardiology and Director of Interventional Cardiology at Stanford University School of Mediciner. Dr. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology, the American Heart Association, and the Society of Cardiovascular Angiography and Interventions. He has been elected to the American Society for Clinical Investigation. Dr. Fearon’s primary area of research interest is in coronary physiology. He was the US principal investigator and senior author of the FAME trial, published in the New England Journal of Medicine and was a co-principal investigator and senior author of the FAME 2 trial, also published in the New England Journal of Medicine. He is now the principal investigator of the international FAME 3 trial comparing bypass surgery to fractional flow reserve guided percutaneous coronary intervention. He serves on the editorial board of the Journal of the American College of Cardiology, Circulation, JACC Cardiovascular Interventions, and Circulation: Cardiovascular Interventions. He was the principal investigator on an R01 and is the PI on an R61/R33 NIH award evaluating cardiac allograft vasculopathy early after transplantation. Dr. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement. He was a coauthor on the PARTNER 2A Trial published in the New England Journal of Medicine.
Show Less• Lessons from the ISCHEMIA trial – Cover the plaque for better outcomes
• Q&A with Panel Discussion
Dimitri Karmpaliotis
Director of Rescue the Heart Program, Director CTO, and Advanced Coronary Therapeutics,...
Read MoreDirector of Rescue the Heart Program, Director CTO, and Advanced Coronary Therapeutics, Morristown Medical Center Dimitrios Karmpaliotis, MD, PhD, FACC, FSCAI is Medical Director of the Cardiovascular Rescue and Recovery Program and the Advanced Coronary Therapeutics and Chronic Total Occlusions Program at Morristown Medical Center. Dr. Karmpaliotis was formerly at the Center for Interventional Vascular Therapy at Columbia University Medical Center, where he provided world-class care since 2014. He is a former associate professor of medicine at Columbia University Medical School and formerly served as director of the Chronic Total Occlusions, Complex and High-Risk Angioplasty Program at New York-Presbyterian/Columbia University Medical Center.
Show LessDavid Kandzari
Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service...
Read MoreDr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology of the Piedmont Heart Institute; and Chief Scientific Officer for Piedmont Healthcare in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. Dr. Kandzari is the former Director of Interventional Cardiology Research at the Scripps Clinic in La Jolla, California. Before joining the Scripps faculty, he also served as Chief Medical Officer for the Cordis Corporation, a Johnson & Johnson Company. He has also served as a Medical Officer for the Center for Devices and Radiological Health for the United States Food and Drug Administration. Board certified by the American Board of Internal Medicine and its subspecialty Board of Cardiovascular Disease and Board of Interventional Cardiology, Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 400 studies, book chapters and scientific reviews, and has delivered more than 700 lectures, both nationally and internationally, on a variety of issues related to both interventional and general cardiology. Dr. Kandzari has been consecutively voted as one of Atlanta's Top Doctors by Atlanta Magazine from 2011 to 2021, and is peer-nominated in the top 1% of cardiologists by U.S News and World Report.
Show LessStéphane Rinfret
Dr Stéphane Rinfret is an academic interventional cardiologist and world-renown expert in chronic...
Read MoreDr Stéphane Rinfret is an academic interventional cardiologist and world-renown expert in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). He was appointed chief of interventional cardiology at the McGill University Health Centre (MUHC) and associate professor of medicine at McGill University in 2016 where he built a very active chronic total occlusion (CTO) and Complex Higher-risk but Indicated Procedures (CHIP) program. He has now moved to the US to work with at Emory Healthcare and Emory University, as associate-director of complex PCI and full professor (acting) of Medicine, to pursue his academic career and busy clinical practice, mostly at Emory Saint Joseph's Hospital, the oldest hospital of Atlanta serving a very large population. Dr Rinfret has held several peer-reviewed grants, published over 150 peer-reviewed articles, several abstracts, and has been invited over 300 times to give lectures in the last 10 years. His epidemiological research focuses on health services and outcomes. He is also a high-volume and world-renown coronary operator, performing over 400 percutaneous coronary interventions (PCIs) per year, mostly from the transradial approach and most with complex anatomies. Dr Rinfret was one of the Canadian pioneers in CTO PCI and has contributed to expand access to the technique in Canada and all around the world through sharing his expertise. He is the lead editor of a textbook on CTO PCI published by Springer in 2015, currently being reviewed for a second edition. He has performed over 1200 CTO PCIs since January 2010, one of the largest volumes in the world, including a large number of retrograde procedures, and pursues a very active teaching program of transradial and CTO PCI techniques in Canada and Europe.
Show Less• Optimal Bifurcation PCI – A planned 2-stent strategy - don’t hesitate!
• Q&A with Panel Discussion/Wrap-up
Azeem Latib
Works at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical....
Read MoreWorks at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical. Azeem Latib generally speaks on Bioresorbable Vascular Scaffold (BVS), Drug Eluting Stents (DES), Intravascular Ultrasound (IVUS), Bifurcation, and Intracoronary Imaging.
Show LessMichael Lee
Dr. Michael S. Lee, is an interventional cardiologist, Associate Professor of Medicine and the...
Read MoreDr. Michael S. Lee, is an interventional cardiologist, Associate Professor of Medicine and the Associate Director of Interventional Cardiology Research at the UCLA Medical Center. Dr. Lee has published over 110 (over 70 of which were as first author) peer reviewed articles and chapters. He has also published on topics including antithrombotic therapy in patients with acute coronary syndrome and in percutaneous coronary intervention, protocols to establish heparin dosing regimens, and percutaneous coronary intervention for the treatment of left main disease, saphenous vein grafts, and cardiac allograft vasculopathy who have undergone orthotopic heart transplantation. He is one of the world’s authorities in coronary and peripheral orbital atherectomy.
Show LessJeffrey Moses
An internationally recognized interventional cardiologist, Dr. Moses has performed more than...
Read MoreAn internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.
Show LessElazer Edelman
Elazer Edelman works at MIT, Boston, MA, USA.
Read MoreElazer Edelman works at MIT, Boston, MA, USA.
Show LessOri Ben-Yehuda
Ori Ben-Yehuda, is the Executive Director of the Clinical Trials Center at the Cardiovascular...
Read MoreOri Ben-Yehuda, is the Executive Director of the Clinical Trials Center at the Cardiovascular Research Foundation. A graduate of Tel Aviv University, he completed his fellowship in cardiology at the University of California, San Diego. From 1997 to 2011 he was the Director of the Coronary Care Unit at UCSD where he was also Professor of Medicine. He also served as the Deputy Editor of the Journal of the American College of Cardiology and is presently the Deputy Editor of Structural Heart: the Journal of the Heart Team. Dr. Ben-Yehuda is involved in the design and execution of multiple clinical trials in interventional cardiology.
Show LessManesh Patel
Manesh Patel is the Chief of the Division of Cardiology and the Division of Clinical...
Read MoreManesh Patel is the Chief of the Division of Cardiology and the Division of Clinical Pharmacology. His clinical interests include diagnostic and interventional coronary angiography, peripheral angiography and endovascular intervention. His is involved in several clinical trials involving patients with cardiovascular disease and in cardiac imaging. He is also the Chair of the American College of Cardiology Task Force for Appropriate Use Criteria for Cardiovascular Procedures and is Chair of the American Heart Association Diagnostic and Interventional Cath Committee. Patel's interest in cardiac imaging, quality of care, cardiac devices is also evident in his research. His integration of these efforts into his roles at Duke was recognized in 2010 when he received the prestigious Duke Cardiology Fellowship Mentor Award. In 2011, Dr. Patel was named the endowed John Bush Simpson Assistant Professor of Cardiology. In 2013, Dr. Patel received the Robert M. Califf Faculty clinical research Award. Currently, Dr. Patel is leading an effort to redesign the delivery of care to patients undergoing invasive catheterization procedures in the health system with a specific aim of measure and providing individualized, patient centered, innovative, and efficient care.
Show Less• Vulnerable plaque detection is a pipe-dream
• Q&A with Panel Discussion
Gary Mintz
Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF,...
Read MoreGary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF, New York, NY) and a Director of Transcatheter Cardiovascular Therapeutics (TCT). He is the author of more than 1000 peer reviewed articles, 60 book chapters, 4 books, and 850 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and (especially) intravascular imaging and physiology. In 2005, Dr. Mintz published his single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese. In 2014, Dr. Mintz received the Master of the Masters Career Achievement Award at the TCTAP-Cardiovascular Summit in Seoul, Korea; in 2015 Dr. Mintz received the Chien Foundation Outstanding Lectureship & Lifetime Achievement Award, also presented at TCTAP-Cardiovascular Summit in Seoul, Korea; in 2017 Dr. Mintz received the Outstanding Achievement Award at CBS 2017, Nanjing, China; in 2018 Dr. Mintz received the Career Achievement Award at NFIC in Krakow, Poland; and in 2020 Dr. Mintz received the Jiangsu Friendship Award from the People’s Government of Jiangsu Province, China, the highest award presented to a non-Chinese. He also serves as a Senior Scientist and Advisor at the Medstar Cardiovascular Research Network, Washington, DC. Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University (now part of Drexel University), in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty in 1978 and was ultimately promoted to Professor of Medicine in 1987 before joining CRF in 1991. His past appointments at CRF have included Chief Medical Officer and Editor-in-Chief (and one of the founders) of TCTMD.com.
Show LessJuan Granada
Works at CRF Skirball Center for Innovation, Orangeburg, NY, USA. Features in 13 videos on Wondr...
Read MoreWorks at CRF Skirball Center for Innovation, Orangeburg, NY, USA. Features in 13 videos on Wondr Medical. Juan Granada generally speaks on Mitral, Repair/Replacement, Trans Mitral Valve Implantation (TMVR), Mitral regurgitation, and Bioresorbable Vascular Scaffold (BVS).
Show LessAllen Jeremias
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate...
Read MoreAllen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.
Show LessDavid Cohen
David J. Cohen, MD, MSc is currently Director of Clinical and Outcomes Research at the...
Read MoreDavid J. Cohen, MD, MSc is currently Director of Clinical and Outcomes Research at the Cardiovascular Research Foundation (New York, NY) and Director of Academic Affairs at St. Francis Hospital (Roslyn, NY). Previously, he was Professor of Medicine at the University of Missouri–Kansas City and Director of Cardiovascular Research and Medical Director of Health Economics and Technology Assessment at Saint Luke’s Mid America Heart Institute. Heart Institute where he continues to direct the Health Economics and Technology Assessment Group. Dr. Cohen earned his M.D. at Harvard Medical School and his Master's degree in Health Policy at the Harvard School of Public Health. He did his clinical training at Brigham and Women's Hospital and was a clinical and research fellow in cardiology at Beth Israel Hospital for five years. Dr. Cohen is a practicing interventional cardiologist with a focus on structural and valvular heart disease. His research focuses on the application of formal cost-effectiveness methodology to novel interventions for cardiovascular disease (CVD), the extension of traditional cardiovascular outcomes research to include patient-centered outcomes, and the development and evaluation of instruments for assessing CVD patients’ health status and preferences. He is also active in research to determine the short- and long-term outcomes of new devices for percutaneous coronary revascularization and identifying the optimal target populations and techniques for these devices. Dr. Cohen has published more than 500 original articles in leading journals, including the New England Journal of Medicine, Lancet, JAMA, Circulation, and the Journal of the American College. Dr. Cohen serves on the editorial board for the American Heart Journal, JACC Interventions, and Circulation and reviews for the American Journal of Cardiology, Journal of the American College of Cardiology, New England Journal of Medicine, JAMA, and Medical Decision Making.
Show LessEvan Shlofmitz
Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at...
Read MoreDr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at St. Francis Hospital - The Heart Center in Roslyn, NY. He completed a fellowship in Interventional Cardiology at Georgetown University/MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC), a Cardiovascular Disease fellowship at Northwell Health and served as Chief Resident for Internal Medicine at New York Presbyterian Queens. He serves on SCAI's IHD Council and is a co-director of Optimizing PCI (OPCI). His research interests have centered on intravascular imaging, the treatment of calcified coronary artery disease, in-stent restenosis and the optimization of stent implantation, with more than 100 publications in peer-reviewed journals.
Show LessJeffrey Moses
An internationally recognized interventional cardiologist, Dr. Moses has performed more than...
Read MoreAn internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.
Show LessRichard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read MoreDr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show LessZiad Ali
Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational...
Read MoreZiad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.
Show LessRichard Shlofmitz
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The...
Read MoreDr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
Show LessSupporters
This activity has been funded by educational grants from:
Abbott Vascular - Abiomed - Amgen
Astra Zeneca - Boston Scientific - Chiesi
CSI - Medtronic - InfraredX
Philips - Shockwave - Siemens
Accreditation & Evaluation
Activity Evaluation
Evaluation will address content, presentation, possible bias, and future educational needs.
CME Accreditation and Designation
St. Francis Hospital & Heart Center is accredited by The Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians. St. Francis Hospital & Heart Center designates this live activity for a maximum of 12.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
It is the policy of the St. Francis Hospital & Heart Center to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational programs. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.